Qianru Zhao, Qingya Zhang, Xiaopeng Zhao, Zheng Tian, Mingli Sun, Lian He
{"title":"MG53: A new protagonist in the precise treatment of cardiomyopathies","authors":"Qianru Zhao, Qingya Zhang, Xiaopeng Zhao, Zheng Tian, Mingli Sun, Lian He","doi":"10.1016/j.bcp.2024.116057","DOIUrl":"https://doi.org/10.1016/j.bcp.2024.116057","url":null,"abstract":"","PeriodicalId":503931,"journal":{"name":"Biochemical Pharmacology","volume":"110 4","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139817673","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
N. Morioka, Yoki Nakamura, K. Hisaoka-Nakashima, Yoshihiro Nakata
{"title":"High mobility group box-1: A therapeutic target for analgesia and associated symptoms in chronic pain","authors":"N. Morioka, Yoki Nakamura, K. Hisaoka-Nakashima, Yoshihiro Nakata","doi":"10.1016/j.bcp.2024.116058","DOIUrl":"https://doi.org/10.1016/j.bcp.2024.116058","url":null,"abstract":"","PeriodicalId":503931,"journal":{"name":"Biochemical Pharmacology","volume":"191 S529","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139812806","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Metabolism and Interactions of Antileprosy Drugs.","authors":"J. George","doi":"10.22541/au.158584227.73323001","DOIUrl":"https://doi.org/10.22541/au.158584227.73323001","url":null,"abstract":"Leprosy is a chronic infectious disease caused my Mycobacterium leprae that primarily affects peripheral nervous system and extremities and is prevalent in tropical countries. Treatment for leprosy with multidrug regimens is very effective compared to monotherapy especially in multibacillary cases. The three major antileprosy drugs currently in use are 4, 4'-diaminodiphenyl sulfone (DDS, dapsone), rifampicin, and clofazimine. During multidrug therapy, the potent antibiotic rifampicin induces the metabolism of dapsone, which results in decreased plasma half-life of dapsone and its metabolites. Furthermore, rifampicin induces its own metabolism and decreases its half-life during monotherapy. Rifampicin upregulates several hepatic microsomal drug-metabolizing enzymes, especially cytochrome P450 (CYP) family that in turn induce the metabolism of dapsone. Clofazimine lacks significant induction of any drug-metabolizing enzyme including CYP family and does not interact with dapsone metabolism. Rifampicin does not induce clofazimine metabolism during combination treatment. Administration of dapsone in the acetylated form (acedapsone) can release the drug slowly into circulation up to 75 days and could be useful for the effective treatment of paucibacillary cases along with rifampicin. This review summarizes the major aspects of antileprosy drug metabolism and drug interactions and the role of cytochrome P450 family of drug metabolizing enzymes, especially CYP3A4 during multidrug regimens for the treatment of leprosy.","PeriodicalId":503931,"journal":{"name":"Biochemical Pharmacology","volume":"124 46","pages":"113993"},"PeriodicalIF":0.0,"publicationDate":"2020-04-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141210128","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
